6,106
Views
53
CrossRef citations to date
0
Altmetric
Review

Rapid diagnosis of SARS-CoV-2 using potential point-of-care electrochemical immunosensor: Toward the future prospects

, , , , , & ORCID Icon show all
Pages 126-142 | Received 04 Nov 2020, Accepted 23 Dec 2020, Published online: 15 Jan 2021

References

  • WHO. WHO Coronavirus Disease (COVID-19) Dashboard. Geneva: WHO. Last access date November 03, 2020. https://covid19.who.int/.
  • WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019 nCoV) infection is suspected: interim guidance. Geneva: WHO; 2020. Last access date November 03, 2020. https://apps.who.int/iris/handle/10665/330893.
  • WHO. Infection prevention and control for long-term care facilities in the context of COVID-19: interim guidance. Geneva: World Health Organization; 2020. Last access date November 03, 2020. https://apps.who.int/iris/bitstream/handle/10665/331508/WHO-2019-nCoV-IPC_long_term_care-2020.1-eng.pdf.
  • WHO. Advice on the use of masks in the context of COVID-19. Geneva: World Health Organization. Last access date November 03, 2020. https://www.who.int/publications/i/item/advice-on-the-use-of-masks-in-the-community-during-home-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak.
  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316.
  • Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032.
  • Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20. Euro Surveill. 2020;25(5):28.
  • Sheikhzadeh E, Eissa S, Ismail A, Zourob M. Diagnostic techniques for COVID-19 and new developments. Talanta. 2020;220:121392. doi:10.1016/j.talanta.2020.121392.
  • Olofsson S, Brittain-Long R, Andersson LM, Westin J, Lindh M. PCR for detection of respiratory viruses: seasonal variations of virus infections. Expert Rev Anti Infect Ther. 2011;9(8):615–626. doi:10.1586/eri.11.75.
  • Saijo M, Morikawa S, Kurane I. Real-time quantitative polymerase chain reaction for virus infection diagnostics. Expert Opin Med Diagn. 2008;2(10):1155–1171. doi:10.1517/17530059.2.10.1155.
  • Whitman JD, Hiatt J, Mowery CT, et al. Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nat Biotechnol. 2020;38(10):1174–1183. doi:10.1038/s41587-020-0659-0.
  • Peeling RW, Wedderburn CJ, Garcia PJ, et al. Serology testing in the COVID-19 pandemic response. Lancet. 2020;20(9):E245–E249.
  • Tyagi A, Nigam S, Chauhan RS. A concise review of baseline facts of SARS-CoV-2 for interdisciplinary research. ChemistrySelect. 2020;5(35):10897–10923. doi:10.1002/slct.202002420.
  • Woo PCY, Lau SKP, Lam CSF, et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol. 2012;86(7):3995–4008. doi:10.1128/JVI.06540-11.
  • Liu Y, Liang C, Xin L, et al. The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020. Eur J Med Chem. 2020;206:112711. doi:10.1016/j.ejmech.2020.112711.
  • Zhang L, Guo H. Biomarkers of COVID-19 and technologies to combat SARS-CoV-2. Adv Biomarker Sci Technol. 2020;2:1–23. doi:10.1016/j.abst.2020.08.001.
  • Gerard C, Maggipinto G, Minon J-M. COVID-19 and ABO blood group: another viewpoint. Br J Haematol. 2020; 190 (2):e93–e94. doi:10.1111/bjh.16884.
  • Hu T, Liu Y, Zhao M, Zhuang Q, Xu L, He Q. A comparison of COVID-19, SARS and MERS. PeerJ. 2020;8:e9725. doi:10.7717/peerj.9725.
  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7.
  • Ahmed Taha Al-Juboori B, Arsad N, Al Mashhadany YI. An analysis review, detection coronavirus disease 2019 (COVID-19) based on biosensor application. Sensors. 2020;20(23):6764. doi:10.3390/s20236764.
  • Teklemariam AD, Samaddar M, Alharbi MG, et al. Biosensor and molecular-based methods for the detection of human coronaviruses: a review. Mol Cell Probes. 2020;54:101662. doi:10.1016/j.mcp.2020.101662.
  • Medhi R, Srinoi P, Ngo N, Tran H-V, Lee TR. Nanoparticle-based strategies to combat COVID-19. ACS Appl Nano Mater. 2020;3(9):8557–8580. doi:10.1021/acsanm.0c01978.
  • Chauhan DS, Prasad R, Srivastava R, et al. Comprehensive review on current interventions, diagnostics, and nanotechnology perspectives against SARS-CoV-2. Bioconjug Chem. 2020;31(9):2021–2045. doi:10.1021/acs.bioconjchem.0c00323.
  • Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi:10.1126/science.abb2507.
  • Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457–460. doi:10.1007/s11427-020-1637-5.
  • Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: friend or foe? Life Sci. 2020; 256:117900. doi:10.1016/j.lfs.2020.117900.
  • Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: a review. J Infect Public Health. 2020;13(11):1619–1629. doi:10.1016/j.jiph.2020.07.001.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
  • Xu Z, Sh L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X.
  • Zhong J, Tang J, Ye C, et al. The immunology of COVID-19: is immune modulation an option for treatment? Lancet Rheumatol. 2020;2:428–436.
  • Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020;22(2):69–71. doi:10.1016/j.micinf.2020.01.004.
  • Martinez RM. Clinical samples for SARS-CoV-2 detection: review of the early literature. Clin Microbiol Newsl. 2020;42(15):121–127. doi:10.1016/j.clinmicnews.2020.07.001.
  • Lohse S, Pfuhl T, Berkó-Göttel B, et al. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. Lancet Infect Dis. 2020;20(11):P1231–P1232. doi:10.1016/S1473-3099(20)30362-5.
  • Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–1179. doi:10.1056/NEJMc2001737.
  • Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488. doi:10.1001/jama.2020.3204.
  • Pan Y, Zhang D, Yang P, et al. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020;20(4):411–412. doi:10.1016/S1473-3099(20)30113-4.
  • Yuan J, Kou S, Liang Y, et al. PCR assays turned positive in 25 discharged COVID-19 patients. Clin Infect Dis. 2020;71(16):2230–2232.
  • Tang X, Zhao S, He D, et al. Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen, China. Infect Control Hosp Epidemiol. 2020;41(9):1110–1112.
  • Li Y, Yao L, Li J, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020;92(7):903–908. doi:10.1002/jmv.25786.
  • Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844.
  • Huang Y, Chen S, Yang Z, et al. SARS-CoV-2 viral load in clinical samples from critically ill patients. Am J Respir Crit Care Med. 2020;201(11):1435–1438. doi:10.1164/rccm.202003-0572LE.
  • Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March: retrospective cohort study. BMJ. 2020;369:m1443.
  • Lescure FX, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020;20(6):697–706.
  • Chen W, Lan Y, Yuan X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020;9(1):469–473. doi:10.1080/22221751.2020.1732837.
  • Guo WL, Jiang Q, Ye F, et al. Effect of throat washings on detection of 2019 novel coronavirus. Clin Infect Dis. 2020;71(8):1980–1981.
  • Zhang X, Chen X, Chen L, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18(3):360–362.
  • Li D, Jin M, Bao P, et al. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3(5):e208292. doi:10.1001/jamanetworkopen.2020.8292.
  • Saiegh FA, Ghosh R, Leibold A, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020;91(8):846–848. doi:10.1136/jnnp-2020-323522.
  • Christine MZ, Virol J. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency. Virus Encephalitis. 1999;73(12):10480–10488.
  • Bwire GM, Paulo LS. Coronavirus disease-2019: is fever an adequate screening for the returning travelers. Trop Med Health. 2020;48(1):14. doi:10.1186/s41182-020-00201-2.
  • Parihar A, Ranjan P, Sanghi SK, et al. Point-of-care biosensor-based diagnosis of COVID-19 holds promise to combat current and future pandemics. ACS Appl Bio Mater. 2020;3(11):7326–7343. doi:10.1021/acsabm.0c01083.
  • Feng W, Newbigging AM, Le C, et al. Molecular diagnosis of COVID-19: challenges and research needs. Anal Chem. 2020; 92 (15):10196–10209. doi:10.1021/acs.analchem.0c02060.
  • Huang WE, Lim B, Hsu C-C, et al. RT‐LAMP for rapid diagnosis of coronavirus SARS‐CoV‐2. Microb Biotechnol. 2020;13(4):950–961. doi:10.1111/1751-7915.13586.
  • Broughton JP, Deng X, Yu G, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020;38(7):870–874. doi:10.1038/s41587-020-0513-4.
  • Yu L, Wu S, Hao X, et al. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform. Clin Chem. 2020;66(7):975–977. doi:10.1093/clinchem/hvaa102.
  • Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004;4(6):337–348. doi:10.1016/S1473-3099(04)01044-8.
  • Butowt R, Bilinska K. SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci. 2020;11(9):1200–1203. doi:10.1021/acschemneuro.0c00172.
  • Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. AJR Am J Roentgenol. 2020;214(6):1280–1286. doi:10.2214/AJR.20.22954.
  • Fani M, Zandi M, Soltani S, et al. Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics. Biotechnol Appl Biochem. 2020. doi:10.1002/bab.2033.
  • Ippolito D, Maino C, Pecorelli A, et al. Chest X-ray features of SARS-CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals. Respir Med. 2020;170:106036. doi:10.1016/j.rmed.2020.106036.
  • Chandra TB, Verma K, Singh BK, et al. Coronavirus disease (COVID-19) detection in Chest X-Ray images using majority voting based classifier ensemble. Expert Syst Appl. 2021;165:113909. doi:10.1016/j.eswa.2020.113909.
  • Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi:10.1016/S1473-3099(20)30086-4.
  • Javalkote VS, Kancharla N, Bhadra B, et al. CRISPR-based assays for rapid detection of SARS-CoV-2. Methods. 2020. doi:10.1016/j.ymeth.2020.10.003.
  • Moulahoum H, Ghorbanizamani F, Zihnioglu F, et al. How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing. Talanta. 2021;222:121534. doi:10.1016/j.talanta.2020.121534.
  • Baek YH, Um J, Antigua KJC, et al. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2. Emerg Microbes Infect. 2020;9(1):998–1007. doi:10.1080/22221751.2020.1756698.
  • Lin D, Liu L, Zhang M, et al. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak. Eur J Clin Microbiol Infect Dis. 2020;39(12):2271–2277. doi:10.1007/s10096-020-03978-6.
  • Chen Z, Zhang Z, Zhai X, et al. Rapid and sensitive detection of anti-SARS-CoV-2 IgG, using lanthanide-doped nanoparticles-based lateral flow immunoassay. Anal Chem. 2020;92(10):7226–7231. doi:10.1021/acs.analchem.0c00784.
  • Feng M, Chen J, Xun J, et al. Development of a sensitive immunochromatographic method using lanthanide fluorescent microsphere for rapid serodiagnosis of COVID-19. ACS Sens. 2020;5(8):2331–2337. doi:10.1021/acssensors.0c00927.
  • Baker AN, Richards S-J, Guy CS, et al. The SARS-COV-2 spike protein binds sialic acids and enables rapid detection in a lateral flow point of care diagnostic device. 2020;6(11):2046–2052. doi:10.1021/acscentsci.0c00855.
  • Maddali H, Miles CE, Kohn J, et al. Optical biosensors for virus detection: prospects for COVID-19. ChemBioChem. 2020;21:1–15. doi:10.1002/cbic.202000744.
  • Xin Ting Zhao V, It Wong T, Ting Zheng X, Nee Tan Y, Zhou X. Colorimetric biosensors for point-of-care virus detections. Mater Sci Energy Technol. 2019;3:237–249. doi:10.1016/j.mset.2019.10.002.
  • Nikolaev EN, Indeykina MI, Brzhozovskiy AG, et al. Mass-spectrometric detection of SARS-CoV-2 virus in scrapings of the epithelium of the nasopharynx of infected patients via nucleocapsid N protein. J Proteome Res. 2020;19(11):4393–4397. doi:10.1021/acs.jproteome.0c00412.
  • Gouveia D, Miotello G, Gallais F, et al. Proteotyping SARS-CoV-2 virus from nasopharyngeal swabs: a proof-of-concept focused on a 3 min mass spectrometry window. J. Proteome Res. 2020;19(11):4407–4416. doi:10.1021/acs.jproteome.0c00535.
  • Renuse S, Vanderboom PM, Maus AD, et al. Development of mass spectrometry-based targeted assay for direct detection of novel SARS-CoV-2 coronavirus from clinical specimens. medRxiv. 2020. doi:10.1101/2020.08.05.20168948.
  • Xia Lim RR, Bonanni A. The potential of electrochemistry for the detection of coronavirus-induced infections. Trends Anal Chem. 2020;133:116081. doi:10.1016/j.trac.2020.116081.
  • Goral VN, Zaytseva NV, Baeumner AJ. Electrochemical microfluidic biosensor for the detection of nucleic acid sequences. Lab Chip. 2006;6(3):414–421. doi:10.1039/b513239h.
  • Pashchenko O, Shelby T, Banerjee T, et al. A comparison of optical, electrochemical, magnetic, and colorimetric point-of-care biosensors for infectious disease diagnosis. ACS Infect Dis. 2018;4(8):1162–1178. doi:10.1021/acsinfecdis.8b00023.
  • Kaushik AK, Dhau JS, Gohel H, et al. Electrochemical SARS-CoV-2 sensing at point-of-care and artificial intelligence for intelligent COVID-19 management. ACS Appl Bio Mater. 2020;3(11):7306–7325. doi:10.1021/acsabm.0c01004.
  • Layqah LA, Eissa S. An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes. Microchim Acta. 2019;186(4):224. doi:10.1007/s00604-019-3345-5.
  • Nidzworski D, Siuzdak K, Niedziałkowski P, et al. A rapid-response ultrasensitive biosensor for influenza virus detection using antibody modified boron-doped diamond. Sci Rep. 2017;7(1):15707. doi:10.1038/s41598-017-15806-7.
  • Ravina H, Mohan PS, Gill A. Kumar Hemagglutinin gene based biosensor for early detection of swine flu (H1N1) infection in human. Int J Biol Macromol. 2019;130:720–726. doi:10.1016/j.ijbiomac.2019.02.149.
  • Maity A, Sui X, Jin B, et al. Resonance-frequency modulation for rapid, point-of-care Ebola-glycoprotein diagnosis with a graphene-based field-effect biotransistor. Anal Chem. 2018;90(24):14230–14238. doi:10.1021/acs.analchem.8b03226.
  • Vadlamani BS, Uppal T, Verma SC, et al. Functionalized TiO2 nanotube-based electrochemical biosensor for rapid detection of SARS-CoV-2. Sensors. 2020;20(20):5871. doi:10.3390/s20205871.
  • Justino CIL, Gomes AR, Freitas AC, et al. Graphene based sensors and biosensors. Trends Anal Chem. 2017;91:53–66. doi:10.1016/j.trac.2017.04.003.
  • Vermisoglou E, Panacek D, Jayaramulu K, et al. Human virus detection with graphene-based materials. Biosens Bioelectron. 2020;166:112436. doi:10.1016/j.bios.2020.112436.
  • Bonanni A. Advances on the use of graphene as a label for electrochemical biosensors. ChemElectroChem. 2020;7(20):4157–4110. doi:10.1002/celc.202001184.
  • Syu Y-C, Hsu W-E, Lin C-T. Review—field-effect transistor biosensing: devices and clinical applications. ECS J Solid State Sci Technol. 2018;7(7):Q3196–Q3207. doi:10.1149/2.0291807jss.
  • Seo G, Lee G, Kim MJ, et al. Rapid detection of COVID-19 causative virus (SARSCoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano. 2020;14(9):12257–11021. doi:10.1021/acsnano.0c06726.
  • Gaurav A, Shukla P. Rapid detection of covid-19 causative virus (sars-cov-2) using FET-based biosensor. Int Res J Modernizat Eng Technol Sci. 2020;2:1207–1214.
  • Xian M, Carey PH, Fares C, et al. Rapid electrochemical detection for SARS-CoV-2 and cardiac troponin I using low-cost, disposable and modular biosensor system. Paper presented at the IEEE Research and Applications of Photonics in Defense Conference (RAPID), August 10–12, 2020, Miramar Beach, FL. doi:10.1109/RAPID49481.2020.9195689.
  • Torrente-Rodríguez RM, Lukas H, Tu J, et al. SARS-CoV-2 RapidPlex: a graphene-based multiplexed telemedicine platform for rapid and low-cost COVID-19 diagnosis and monitoring. Matter. 2020;3(6):1981–1998. doi:10.1016/j.matt.2020.09.027.
  • Zhou W, Gao X, Liu D, et al. Gold nanoparticles for in vitro diagnostics. Chem Rev. 2015;115:0575–10636.
  • Saha K, Agasti SS, Kim C, et al. Gold nanoparticles in chemical and biological sensing. Chem Rev. 2012;112(5):2739–2779. doi:10.1021/cr2001178.
  • Chen D, Feng H, Li J. Graphene oxide: preparation, functionalization, and electrochemical applications. Chem Rev. 2012;112(11):6027–6053. doi:10.1021/cr300115g.
  • Mahari S, Roberts A, Shahdeo D, et al. eCovSens-ultrasensitive novel in-house built printed circuit board based electrochemical device for rapid detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2. bioRxiv. 2020. doi:10.1101/2020.04.24.059204.
  • Ali MA, Hu C, Jahan S, et al. Sensing of COVID-19 antibodies in seconds via aerosol jet printed three dimensional electrodes. medRxiv. 2020; doi:10.1101/2020.09.13.20193722.
  • Alafeef M, Dighe K, Moitra P, et al. Rapid, ultrasensitive, and quantitative detection of SARS-CoV-2 using antisense oligonucleotides directed electrochemical biosensor chip. ACS Nano. 2020;14(12):17028–17045. doi:10.1021/acsnano.0c06392.
  • Zhao H, Liu F, Xie W, et al. Ultrasensitive supersandwich-type electrochemical sensor for SARS-CoV-2 from the infected COVID-19 patients using a smartphone. Sens Actuators B Chem. 2021;327:128899. doi:10.1016/j.snb.2020.128899.
  • Berggren C, Bjarnason B, Johansson G. Capacitive biosensors. Electroanalysis. 2001;13(3):173–180. doi:10.1002/1521-4109(200103)13:3<173::AID-ELAN173>3.0.CO;2-B.
  • Rashed MZ, Kopechek JA, Priddy MC, et al. Rapid detection of SARS-CoV-2 antibodies using electrochemical impedance-based detector. Biosens Bioelectron. 2021;171:112709. doi:10.1016/j.bios.2020.112709.
  • Chaibun T, Puenpa J, Puenpa T, et al. Rapid electrochemical detection of coronavirus SARS-CoV-2. Research Square. doi:10.21203/rs.3.rs-86933/v1.
  • Yousefi H, Mahmud A, Chang D, et al. Detection of SARS-CoV-2 viral particles using direct, reagent-free electrochemical sensing. ChemRvix. 2020.
  • Ambrosi A, Pumera M. 3D-printing technologies for electrochemical applications. Chem Soc Rev. 2016;45(10):2740–2755. doi:10.1039/c5cs00714c.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.